⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23346857 | 0.65 | — | — | |
| SCHEMBL4166096 | 0.65 | — | — | |
| SCHEMBL2094171 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL27654326 | 0.63 | — | — | |
| SCHEMBL7334182 | 0.60 | — | — | |
| SCHEMBL9673094 | 0.58 | — | — | |
| SCHEMBL23234265 | 0.58 | MEN1 (0.41) | — | |
| SCHEMBL3193719 | 0.58 | — | — | |
| SCHEMBL1117822 | 0.58 | — | — | |
| SCHEMBL23848163 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | claimed |
| EP-4272832-A2 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| WO-2020156311-A1 | PYRIDAZINE DERIVATIVE INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF | 江苏豪森药业集团有限公司 | 2020-08-06 | — | — | WO | disclosed |
| EP-2867228-B1 | FUNGICIDAL HETEROCYCLIC CARBOXAMIDES | DU PONT (US) | 2017-07-26 | — | — | EP | disclosed |
| EP-2986601-B1 | FUNGICIDAL CARBOXAMIDES | DU PONT (US) | 2017-06-07 | — | — | EP | disclosed |
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | disclosed |